Investigators from academic and cancer research institutions in Europe are invited to submit a note of intent for a new cancer research project on or before 30 April 2017.
Swiss Bridge is a private foundation associated with the Swiss Cancer League, the Swiss Cancer Research foundation and the Union for International Cancer Control (UICC), and supports high-quality cancer research in Europe.
This year, young investigators (<45) with projects focusing on the tumour microenvironment are eligible for application.
The proposals will be evaluated by an international scientific jury.
6 – 8 investigators will be shortlisted and invited to submit a detailed research application by end of July 2017.
Upon peer review and recommendation from the scientific jury, up to 3 projects will receive funding amounting to a total support of 500,000 Swiss francs.
The winners will be invited to an award ceremony to be held in Zurich on 25 October 2017.
The entire note of intent including attachments may not exceed 6 pages (3000 words) and must include:
Please ensure the information provided in your proposal is complete and adheres to the above guidelines before submitting to swissbridge@swisscancer.ch
For more details, read about the prize here.
Source: Swiss Bridge
The World Cancer Declaration recognises that to make major reductions in premature deaths, innovative education and training opportunities for healthcare workers in all disciplines of cancer control need to improve significantly.
ecancer plays a critical part in improving access to education for medical professionals.
Every day we help doctors, nurses, patients and their advocates to further their knowledge and improve the quality of care. Please make a donation to support our ongoing work.
Thank you for your support.